Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-20,000
Closed -$535K 130
2014
Q4
$535K Buy
20,000
+10,000
+100% +$258K 0.26% 29
2014
Q3
$243K Buy
+10,000
New +$253K 0.13% 70

Other funds holding HOLX

Piper Sandler & Co's HOLX Position: Q1 2015 in Review

Piper Sandler & Co sold out of Hologic (HOLX) in Q1 2015, closing a stake of 20,000 shares — an estimated $535K sold.

Piper Sandler & Co first reported a position in HOLX in Q3 2014 and held it in 2 quarters. The position peaked at $535K in Q4 2014. 393 funds tracked by Wall St. Rank hold HOLX as of Q1 2015.

  • Piper Sandler & Co reported no remaining Hologic position as of Q1 2015 after selling out during the quarter.
  • Piper Sandler & Co sold 20,000 Hologic shares in Q1 2015, an estimated $535K.
  • Piper Sandler & Co first reported a position in Hologic in Q3 2014 and held it in 2 quarters.
  • Piper Sandler & Co's Hologic position peaked at $535K in Q4 2014.
  • 393 funds tracked by Wall St. Rank held Hologic as of Q1 2015.

Based on Piper Sandler & Co's 13F filing for Q1 2015, filed 15 May 2015.